News & Press Releases
Filter by:
Mintz Advises on Eupraxia Pharmaceuticals $63.2 Million Public Offering
February 27, 2026
Mintz advised the underwriters in connection with Eupraxia Pharmaceuticals’ $63.2 million public offering.
5th Circuit Rejects FCC Rule, Says TCPA Allows Any Kind of Consent for Marketing Calls
February 27, 2026
Communications Daily featured insights from Member Esteban Morales in an article about a ruling from the 5th U.S. Circuit Court of Appeals which said that despite an FCC ruling that required prior written consent for telemarketing calls, the Telephone Consumer Protection Act indicates that oral consent is enough.
Mintz Represents Vercept in its Sale to Leading AI Company Anthropic
February 27, 2026
Mintz advised Vercept, a Seattle-based computer-use AI startup, in its sale to Anthropic, the leading AI safety and research company developing frontier-scale models and best known for its Claude family of large language models (LLMs).
Inflexion's John DiGiovanni Sees ‘Exciting’ AI Use Cases in Healthcare; Tariff Risk Has Peaked, Victor Capital’s Doug Korn Says
February 26, 2026
PE Hub featured insights from Private Equity Practice Co-chair Matthew Simpson in an article that discusses the impact of tariffs on dealmaking.
Mintz Advises Sixth Street on $500 Million Strategic Financing Facility with Beam Therapeutics
February 25, 2026
Mintz advised global investment firm Sixth Street in connection with its $500 million strategic financing facility with Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing.
Mintz Lands IP Pro from Wilson Sonsini in San Francisco
February 24, 2026
Law360 Pulse featured the addition of Member T.O. Kong to Mintz's Intellectual Property Division in San Francisco.
